During the past decade, Tyumen State Medical University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tyumen State Medical University" are "Arterial Thrombosis" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Perioperative Bleeding" (1 trials), "Rotavirus Infection" (1 trials) and "Venous Thrombosis" (1 trials). Many other conditions were trialed in "Tyumen State Medical University" in a lesser frequency.

Most popular intervention types in "Tyumen State Medical University" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials), "Perioperative hypertension-avoidance strategy" (1 trials), "Perioperative hypotension-avoidance strategy" (1 trials) and "Placebo (Saline)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tyumen State Medical University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tyumen State Medical University". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tyumen State Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tyumen State Medical University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".